These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Characterization of in vitro dengue virus resistance to carrageenan. Talarico LB; Damonte EB J Med Virol; 2016 Jul; 88(7):1120-9. PubMed ID: 26694200 [TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo. Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029 [TBL] [Abstract][Full Text] [Related]
10. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus. Franco EJ; Pires de Mello CP; Brown AN Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551 [TBL] [Abstract][Full Text] [Related]
11. Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. Vasilakis N; Deardorff ER; Kenney JL; Rossi SL; Hanley KA; Weaver SC PLoS Pathog; 2009 Jun; 5(6):e1000467. PubMed ID: 19503824 [TBL] [Abstract][Full Text] [Related]
12. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry. Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425 [TBL] [Abstract][Full Text] [Related]
13. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. Chew MF; Tham HW; Rajik M; Sharifah SH J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692 [TBL] [Abstract][Full Text] [Related]
14. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells. Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230 [TBL] [Abstract][Full Text] [Related]
15. A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-dengue and anti-Zika virus activity. Ruan J; Rothan HA; Zhong Y; Yan W; Henderson MJ; Chen F; Fang S Sci Rep; 2019 Jul; 9(1):10901. PubMed ID: 31358863 [TBL] [Abstract][Full Text] [Related]
16. Haddad JG; Koishi AC; Gaudry A; Nunes Duarte Dos Santos C; Viranaicken W; Desprès P; El Kalamouni C Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091703 [TBL] [Abstract][Full Text] [Related]
17. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane. Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975 [TBL] [Abstract][Full Text] [Related]
19. Characterization of dengue virus resistance to brequinar in cell culture. Qing M; Zou G; Wang QY; Xu HY; Dong H; Yuan Z; Shi PY Antimicrob Agents Chemother; 2010 Sep; 54(9):3686-95. PubMed ID: 20606073 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library. Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]